Search by Drug Name or NDC
NDC 78206-0118-01 CELESTONE SOLUSPAN 3; 3 mg/mL; mg/mL Details
CELESTONE SOLUSPAN 3; 3 mg/mL; mg/mL
CELESTONE SOLUSPAN is a INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Organon LLC. The primary component is BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE.
Product Information
NDC | 78206-0118 |
---|---|
Product ID | 78206-118_501138c6-f3e1-4c97-84e0-ff0e72f5b9a4 |
Associated GPIs | 22109902101810 |
GCN Sequence Number | 006758 |
GCN Sequence Number Description | betamethasone acetate,sod phos VIAL 6 MG/ML INJECTION |
HIC3 | P5A |
HIC3 Description | GLUCOCORTICOIDS |
GCN | 82300 |
HICL Sequence Number | 002881 |
HICL Sequence Number Description | BETAMETHASONE ACETATE/BETAMETHASONE SODIUM PHOSPHATE |
Brand/Generic | Brand |
Proprietary Name | CELESTONE SOLUSPAN |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Betamethasone Acetate and Betamethasone Sodium Phosphate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SUSPENSION |
Route | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; SOFT TISSUE |
Active Ingredient Strength | 3; 3 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
Labeler Name | Organon LLC |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA014602 |
Listing Certified Through | 2024-12-31 |
Package
NDC 78206-0118-01 (78206011801)
NDC Package Code | 78206-118-01 |
---|---|
Billing NDC | 78206011801 |
Package | 1 VIAL, MULTI-DOSE in 1 BOX (78206-118-01) / 5 mL in 1 VIAL, MULTI-DOSE |
Marketing Start Date | 2021-06-01 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 7.97469 |
Pricing Unit | ML |
Effective Date | 2023-01-16 |
NDC Description | CELESTONE SOLUSPAN 30 MG/5 ML |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 4, 5 |
Classification for Rate Setting | B |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis